Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Association of Antenatal Steroid Exposure At 21 To 22 Weeks of Gestation With Neonatal Survival and Survival Without Morbidities

Title: Association of Antenatal Steroid Exposure At 21 To 22 Weeks of Gestation With Neonatal Survival and Survival Without Morbidities
Authors: Chawla, Sanjay; Wyckoff, Myra H; Rysavy, Matthew A; Patel, Ravi Mangal; Chowdhury, Dhuly; Natarajan, Girija; Laptook, Abbot R; Lakshminrusimha, Satyan; Bell, Edward F; Shankaran, Seetha; Van Meurs, Krisa P; Ambalavanan, Namasivayam; Greenberg, Rachel G; Younge, Noelle; Werner, Erika F; Das, Abhik; Carlo, Waldemar A; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
Source: Faculty, Staff and Student Publications
Publisher Information: DigitalCommons@TMC
Publication Year: 2022
Collection: Houston Academy of Medicine-Texas Medical Center (HAM-TMC): DigitalCommons@The Texas Medical Center
Subject Terms: Adrenal Cortex Hormones; Child; Cohort Studies; Female; Humans; Infant; Infant Mortality; Newborn; Male; Morbidity; Pregnancy; Retrospective Studies; Steroids; Maternal and Child Health; Medical Specialties; Medicine and Health Sciences; Pediatrics; Public Health
Description: IMPORTANCE: The provision of antenatal corticosteroids to pregnant patients at gestational age (GA) 22 6/7 weeks or less remains controversial and lacks support from randomized clinical trials. OBJECTIVE: To compare rates of survival and survival without major morbidities among infants born at GA 22 0/7 to 23 6/7 weeks after exposure to antenatal steroids at 22 6/7 weeks' gestation or less vs no exposure to antenatal steroids. DESIGN, SETTING, AND PARTICIPANTS: This cohort study enrolled infants born at GA 22 0/7 to 23 6/7 weeks between January 1, 2016, and December 31, 2019, at centers in the National Institute of Child Health and Human Development Neonatal Research Network. Infants who did not receive intensive care and infants with antenatal steroid exposure after GA 22 6/7 weeks were excluded. EXPOSURE: Infants were classified as having no, partial, or complete exposure to antenatal steroids. MAIN OUTCOMES AND MEASURES: The primary outcome was survival to discharge. The main secondary outcome was survival without major neonatal morbidity. The associations of differential exposures to antenatal steroids with outcomes were evaluated using logistic regression, adjusting for GA, sex, race, maternal education, small for GA status, mode of delivery, multiple birth, prolonged rupture of membranes, year of birth, and Neonatal Research Network center. RESULTS: A total of 431 infants (mean [SD] GA, 22.6 [0.5] weeks; 232 [53.8%] boys) were included, with 110 infants (25.5%) receiving no antenatal steroids, 80 infants (18.6%) receiving partial antenatal steroids, and 241 infants (55.9%) receiving complete antenatal steroids. Seventeen infants were exposed to antenatal steroids at GA 21 weeks. Among infants exposed to complete antenatal steroids, 130 (53.9%) survived to discharge, compared with 30 infants (37.5%) with partial antenatal steroid exposure and 239 infants (35.5%) with no antenatal steroids. Infants born after complete antenatal steroid exposure, compared with those without antenatal steroid exposure, were ...
Document Type: text
File Description: application/pdf
Language: English
Relation: https://digitalcommons.library.tmc.edu/uthmed_docs/2322; https://digitalcommons.library.tmc.edu/context/uthmed_docs/article/3286/viewcontent/Association_of_Antenatal_Steroid_Exposure_at_21_to_22_Weeks_of_Gestation_With_Neonatal_Survival_and_Survival_Without_Morbidities___PMC.pdf
DOI: 10.1001/jamanetworkopen.2022.33331
Availability: https://digitalcommons.library.tmc.edu/uthmed_docs/2322; https://doi.org/10.1001/jamanetworkopen.2022.33331; https://digitalcommons.library.tmc.edu/context/uthmed_docs/article/3286/viewcontent/Association_of_Antenatal_Steroid_Exposure_at_21_to_22_Weeks_of_Gestation_With_Neonatal_Survival_and_Survival_Without_Morbidities___PMC.pdf
Accession Number: edsbas.7D61010E
Database: BASE